In breast, colon, and prostate cancer cell lines exogenously added Gal-3 promotes EMT by its interaction with Trop-2, a highly-glycosylated membrane protein involved in cancer progression (Fig. 6d) [186]. This evidence concerns the gene LGALS3 and cancer.